Family Research Council Faults White House on Abortion Pill Review
The Family Research Council criticized the Trump administration for not reinstating in-person dispensing rules for the abortion pill mifepristone. The group said the White House has only promised a safety review despite pressure from anti-abortion advocates. The item also noted a report that the administration told the Justice Department to delay abortion-related actions until after the midterm elections.
The Family Research Council says mifepristone’s in-person dispensing requirements have not been restored since January 2025. It notes those rules predated the Trump administration and were intended to confirm gestational age and exclude ectopic pregnancy. The group says only a safety review has been pledged, despite pressure from anti-abortion advocates and health experts.
Dr. Christina Francis of AAPLOG questioned how that review is proceeding, citing a recent report and saying years of preparation should have allowed faster action. The article also mentions a report that the White House told the Justice Department to postpone abortion-related moves until after the midterms. The Center for Reproductive Rights disputed the review’s necessity.
The dispute could affect people seeking medication abortion, prescribing clinicians, and advocacy groups on both sides. If in-person dispensing requirements return, access may become more difficult in some regions, while additional clinical screening could be required. A post-midterm delay in Justice